Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I F Tannock

Showing results (71-80 of 183) with videos related to

Pageof 19
Sort By:
Cell and Tissue Kinetics|October 1, 1970
On the existence of a G 0 -phase in the cell cycleF J Burns, I F Tannock
Hematology/Oncology Clinics of North America|February 1, 1994
Clinical relevance of breast cancer biologyA M Oza, I F Tannock
Advances in Cancer Research|January 1, 1993
Lysosomes, lysosomal enzymes, and cancerM J Boyer, I F Tannock
British Journal of Cancer|May 20, 2004
Is there a role for chemotherapy in prostate cancer?C M Canil, I F Tannock
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2018
Avoiding the hazards of misinterpreting treatment effectsE D Saad, I F Tannock
Journal of the National Cancer Institute|January 4, 1989
Flow cytometric analysis of doxorubicin accumulation in cells from human and rodent cell linesC K Luk, I F Tannock
Cancer Treatment Reports|February 1, 1985
Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinomaI F Tannock, W K Evans
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2019
Molecular screening to select therapy for advanced cancer?I F Tannock, J A Hickman
British Journal of Cancer|February 6, 2014
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidenceC M Booth, I F Tannock
Cancer Research|August 15, 1989
Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazoneK J Newell, I F Tannock
Pageof 19

Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Cell and Tissue Kinetics|October 1, 1970
On the existence of a G 0 -phase in the cell cycleF J Burns, I F Tannock
Hematology/Oncology Clinics of North America|February 1, 1994
Clinical relevance of breast cancer biologyA M Oza, I F Tannock
Advances in Cancer Research|January 1, 1993
Lysosomes, lysosomal enzymes, and cancerM J Boyer, I F Tannock
British Journal of Cancer|May 20, 2004
Is there a role for chemotherapy in prostate cancer?C M Canil, I F Tannock
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2018
Avoiding the hazards of misinterpreting treatment effectsE D Saad, I F Tannock
Journal of the National Cancer Institute|January 4, 1989
Flow cytometric analysis of doxorubicin accumulation in cells from human and rodent cell linesC K Luk, I F Tannock
Cancer Treatment Reports|February 1, 1985
Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinomaI F Tannock, W K Evans
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2019
Molecular screening to select therapy for advanced cancer?I F Tannock, J A Hickman
British Journal of Cancer|February 6, 2014
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidenceC M Booth, I F Tannock
Cancer Research|August 15, 1989
Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazoneK J Newell, I F Tannock
Pageof 19